In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Masimo Corp.

http://www.masimo.com/

Latest From Masimo Corp.

Masimo’s MightySat Receives First FDA Clearance For OTC Pulse Oximeter

The first clearance from the US Food and Drug Administration for an over-the-counter fingertip pulse oximeter has gone to Masimo's MightySat Medical, which is now available at the company's website.

Approvals Patient Monitoring

Digital Health Roundup: CES Biggest Hits; Apple Versus Masimo; Insulet Recalls Diabetes App

In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights interviews with industry leaders in medtech and healthtech and demos of some of the most innovative tech seen at CES 2024 in Las Vegas. Hannah Daniel dives into the latest developments in the intellectual property dispute between Apple and Masimo over blood oxygen sensors in the newer Apple Watch models.

Digital Health Artificial Intelligence

MTI 100: Macro Challenges Make Demands Of Newly Resilient Medtechs

Global medtechs had a big enough challenge with COVID-19 and its aftermath before the full-scale regional conflict in Ukraine added more uncertainty to the question of when market normality would return.

Medtech 100 Commercial

New’s We’re Watching: Apple/Masimo Patent Fight Update; Acutus Winds Down; Illumina Bails On Grail

Medtech Insight's News We're Watching highlights medtech industry developments that you may have missed over the last few weeks. In addition to the big news from Acutus, Apple, and Illumina, Masimo scored an important FDA clearance, Beta Bionics announced the US launch of its iLet bionic pancreas for Dexcom’s G7 CGM, and more.

News We're Watching Commercial
See All

Company Information

  • Industry
  • Medical Devices
    • Monitoring Equipment & Devices
  • Other Names / Subsidiaries
    • 52 Discovery, LLC
    • Masimo 25 Sagamore, LLC
    • Masimo Americas, Inc.
    • Masimo Asia Pacific PTE. Ltd.
    • Masimo Australia Pty Ltd
    • Masimo Canada ULC
    • Masimo China Medical Technology Co., Ltd.
    • Masimo de Mexico Holdings I LLC
    • Masimo de Mexico Holdings II LLC
    • Masimo Europe Ltd.
    • Masimo Holdings LLC
    • Masimo Holdings LP
    • Masimo Hong Kong Limited
    • Masimo Importacao e Distribuicao de Produtos Medicos Ltda
    • Masimo International SARL
    • Masimo International Technologies SARL
    • Masimo Japan Kabushiki Kaisha
    • Masimo Medical Technologies India Private Limited
    • Masimo Medikal Ürünler Ticaret Limited Sirketi
    • Masimo Mexico, S.A. de C.V
    • Masimo Öesterreich GmbH
    • Masimo Peru Srl
    • Masimo Semiconductor, Inc.
    • Masimo Sweden AB
    • SEDLine, Inc.
    • SpO2.com, Inc.
    • TNI medical AG
UsernamePublicRestriction

Register